Cancer screening helps detect tumors and precancerous changes before symptoms appear, when treatment is often less invasive and more effective. Cancer screening is especially important for forms of cancer that can develop silently for a long time and are often discovered by chance only during routine examinations.
Why Undergo Cancer Screening Without Symptoms
What is cancer screening? It is a system of routine examinations for people without signs of disease, aimed at the early detection of malignant processes or conditions that may lead to them. The purpose of such programs is that most cancers at stages one and two do not cause pronounced symptoms, while treatment is most effective at these stages, which means that postponing examination until pain, bleeding, or weight loss appears reduces the chances of early diagnosis. Cancer screening does not replace a doctor’s consultation when symptoms are present, but it helps reduce the risk of late detection of breast, cervical, colorectal, prostate, lung, and certain skin cancers. The frequency of examinations depends on age, sex, family history, smoking, infections, hormonal factors, and previous medical conditions.
Breast Cancer Screening
Breast cancer screening is based on a combination of imaging methods and careful attention to changes in the breasts. For women at average risk, mammography every two years starting at age 40 and monthly breast self-examination are the minimum standard for early detection of breast cancer, since small tumors and microcalcifications often cannot be felt and do not cause discomfort. When deciding when to have a mammogram, age, breast tissue density, family history, and previous biopsies are taken into account.
- mammography — from age 40 every 1–2 years depending on the risk group
- breast ultrasound — before age 40 and as a supplement to mammography
- breast MRI — for those at high hereditary risk with a BRCA mutation
- self-examination — monthly on days 5–7 of the menstrual cycle
Mammography remains the primary method of population-based screening because it reduces the likelihood of missing early invasive cancer and ductal carcinoma in situ. Ultrasound is useful in women with dense glandular breast tissue, while MRI is not used routinely for everyone but primarily for women with a confirmed high genetic risk. Self-examination does not replace imaging, but it can help identify skin retraction, nipple discharge, a localized lump, or changes in breast shape between visits to the doctor.
Cervical Cancer Screening
Cervical cancer screening is one of the most effective preventive programs because the disease often develops through a stage of dysplasia, which can be detected and treated in advance. This is why a cervical cytology test and a human papillomavirus test every three years starting at age 21 make it possible to detect precancerous changes long before cancer develops, even if a woman feels well and has no symptoms. When determining how often to undergo cervical cytology screening, age, previous test results, the presence of high-risk HPV, and the gynecologist’s recommendations are taken into account.
Cytological examination evaluates cervical cells, while an HPV test detects viruses associated with the development of dysplasia and cancer. If abnormalities are found, colposcopy, targeted biopsy, and repeat testing after a specified interval may be required. HPV vaccination also plays an important role, but regular screening is still necessary even after vaccination because the vaccine does not protect against all oncogenic types of the virus.
Colorectal Cancer Screening
Colorectal cancer screening reduces mortality by detecting not only early-stage cancer but also adenomatous polyps that can become malignant over time. In clinical practice, colonoscopy every ten years starting at age 45 is the gold standard for detecting colorectal cancer and allows precancerous polyps to be removed at the same time, which is why the procedure is considered both diagnostic and preventive. When determining how often to have a colonoscopy, the quality of bowel preparation, previous examination results, and family history are taken into account.
- fecal occult blood test — annually from age 45
- colonoscopy — every 10 years if the result is negative
- for those with hereditary risk — from age 40 or 10 years before the age of the first case in the family
- sigmoidoscopy — as an alternative every 5 years
A fecal occult blood test is convenient as an initial screening method, but a positive result requires an endoscopic examination. Colonoscopy makes it possible to examine the entire colon, obtain a biopsy, and remove suspicious lesions. In people with hereditary syndromes, inflammatory bowel disease, or close relatives with colorectal cancer, screening begins earlier and is performed more frequently than in the general population.
Prostate Cancer Screening in Men
Prostate cancer screening is discussed individually because prostate tumors vary in their growth rate and clinical significance. For older men, a PSA test and consultation with a urologist once a year starting at age 50, or at age 45 for those with hereditary risk, can help detect prostate cancer at an operable stage, especially if close relatives have already been diagnosed with the disease. How often to take a PSA test is determined after assessing age, life expectancy, changes in PSA levels over time, and the results of a digital rectal examination.
An elevated PSA level does not always mean cancer: it can be affected by benign prostatic hyperplasia, inflammation, recent urological procedures, and even physical activity. Therefore, screening results are not interpreted in isolation but together with clinical findings. If cancer is suspected, prostate MRI, repeat testing, calculation of PSA density, and biopsy may be required.
Lung and Skin Cancer Screening
Lung cancer screening has proven benefits for people at high risk, particularly long-term smokers. At the same time, low-dose computed tomography of the lungs is recommended for smokers with a smoking history of more than 20 years, while an annual dermatologist examination is necessary for people with a large number of moles, because both lung cancer and melanoma may remain asymptomatic for a long time in their early stages. Lung cancer screening is generally considered for people aged 50–80 with a significant smoking history, including those who quit relatively recently.
A dermatologist’s cancer screening examination includes assessing pigmented lesions for asymmetry, irregular borders, uneven color, changes in diameter, and evolution over time. If necessary, dermoscopy and photographic documentation may be used for monitoring over time. For lung cancer, standard fluorography is not considered a complete substitute for low-dose CT in high-risk groups. The frequency and scope of examinations should be based on clinical guidelines, data from large studies, and individual risk factors, since there is no universal screening schedule suitable for everyone. Age, family history, smoking, coexisting conditions, and previous test results are taken into account when selecting a screening program, while findings must be interpreted carefully to avoid both missing significant abnormalities and unnecessary interventions. Cancer screening is most beneficial when it is performed regularly and according to medical indications rather than sporadically.